Stock COR CENCORA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cencora, Inc.

Equities

COR

US03073E1055

Market Closed - Nyse
Other stock markets
 04:00:01 2024-06-07 pm EDT 		5-day change 1st Jan Change
235.5 USD -0.51% Intraday chart for Cencora, Inc. +3.93% +14.65%
12:18am Top law firms in US opioid lawsuits to get hundreds of millions in fees RE
Jun. 03 Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.16 times its sales.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The firm trades with high earnings multiples: 22.98 times its 2024 earnings per share.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
CENCORA, INC. Stock Cencora, Inc.
+14.65% 46.37B
B-
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.26% 187B
C+
MEDTRONIC PLC Stock Medtronic plc
+2.05% 110B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.31% 69.54B
A
DEXCOM, INC. Stock DexCom, Inc.
-6.69% 46.05B
B-
HOYA CORPORATION Stock Hoya Corporation
+7.97% 42.54B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+18.60% 30.72B
B
TERUMO CORPORATION Stock Terumo Corporation
+16.92% 25.62B
A-
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-6.87% 23.32B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-10.63% 22.92B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. COR Stock
  4. Ratings Cencora, Inc.